Following its fresh start with new staff members and a restructured board of directors, KRPIA is stabilizing its operations.

Previously, Korean Research-based Pharmaceutical Industry Association (KRPIA) faced increasing concerns regarding its operations, primarily involving leadership vacancy. The decrease in the number of board members can be explained by reassignments of CEOs in multinational companies, but the frequent resignations of high-ranking officials, including the Head of Policy Business, Kim Min-Young, have sparked inquiries into the association's responsibilities and functions, resulting in criticisms.

KRPIA's operations in the New Year signals a new beginning. Beginning in